News Releases

HCA Holdings Inc. Launches IPO on the New York Stock Exchange Largest Private Equity-Backed IPO Transaction in History Begins NYSE Trading Today

NEW YORK , March 10, 2011- Nashville, Tennessee-based HCA Holdings Inc. today opened for trading on the New York Stock Exchange under the ticker symbol “HCA” after the successful completion of its IPO, in which it raised $3.79 billion in gross proceeds. The completion of HCA’s IPO marks the largest private equity-backed IPO in history.

The IPO of HCA (NYSE: HCA) surpasses the previous record PE-backed IPO by Kinder Morgan  Inc. (NYSE: KMI), which raised $2.9 billion in its IPO last month; Semiconductor Manufacturing International Corp. (NYSE: SMIC), which raised $1.8 billion in 2004; and The Nielsen Company (NYSE: NLSN), which raised $1.65 billion in its IPO in January. The Nielsen Company became the largest U.S. PE-backed IPO in history in January, and was since surpassed by Kinder Morgan, which in turn has been surpassed by HCA. With the successful completion of HCA’s transaction, nine out of 10 of the largest-ever PE-backed IPOs in the world are listed on the NYSE, two of them cross-listed in Hong Kong.

"We believe today's announcement is very positive for all of our stakeholders, and we are pleased to celebrate this important day in the company's history. HCA's success is a reflection of a culture created by our founders, and the dedication of our physicians, nurses, and all our employees, whose compassionate care and commitment have been hallmarks of our company for more than 40 years," said Richard M. Bracken, Chairman and Chief Executive Officer, HCA.

“We are thrilled to welcome HCA, a leading provider of nationwide hospital services, to our growing network of healthcare companies,” said Scott R. Cutler, EVP and Co-Head of U.S. Listings and Cash Execution, NYSE Euronext. “HCA is at the forefront of transforming the U.S. healthcare landscape and we look forward to a lasting partnership with the company and its shareholders.”

Executives and guests of HCA today visited the New York Stock Exchange to celebrate the successful completion of the company’s IPO and first day of trading on the NYSE. To highlight this special occasion, Mr. Bracken rang today’s Opening Bell. 

Background: Top 10 PE-backed IPOS in History (prior to HCA) *:

Name   (Symbol)                                  Market/Date                 $$raised (excl. green shoe) 

Kinder Morgan, Inc. (KMI)

NYSE             2/10/2011

$2.9   billion


NYSE-HK       3/4/2004

$1.8   billion

Nielsen Holdings NV (NLSN)

NYSE             1/25/2011

$1.65 billion

Spirit Aerosystems Holdings Inc (SPR)

NYSE             11/6/2006

$1.4   billion

Huntsman Corp (HUN)

NYSE             2/10/2005

$1.39 billion


NYSE-HK     2/21/2001

$1.36 billion

Hertz Global Holdings (HTZ)

NYSE          11/15/2006

$1.32 billion

Warner Chilcott Ltd (WCRX)

Nasdaq          9/20/2006

$1.06 billion

Dex Media Inc. (DEX)

NYSE             7/21/2004

$1 billion

Intrepid Potash Inc. (IPI)

NYSE             4/21/2008

$960  million

*Source: Dealogic. All dollar proceeds exclude Greenshoe amounts and/or over-allotments.


HCA   Holdings Inc. (NYSE: HCA)

HCA owns and operates approximately 164 hospitals and approximately 106 freestanding surgery centers in 20 states and in London, England. It is dedicated to providing healthcare services that meet each community's local healthcare needs. It seeks to integrate various services to deliver patient care with maximum quality and efficiency. Its approach includes focusing on quality; streamlining operations; sharing technology, equipment and personnel where appropriate; and using economies of scale when contracting for medical supplies and administrative services.

About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies.  The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products.  With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500.  For more information, please visit:

Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext’s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext’s results to differ materially from current expectations include, but are not limited to: NYSE Euronext’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext’s reference document for 2009 ("document de référence") filed with the French Autorité des Marchés Financiers (Filed on April 22, 2010 under No. D.10-0304), 2009 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

Contact: Christiaan Brakman
Phone: 212-656-2094